SANCO/AM/sl/ddg1.d.6(2012)860362
Version milestone
Publication Date
31 Jan 2013
Effective Date
31 Jan 2013
The holder of a Manufacturing Authorisation must manufacture medicinal products so as to ensure that they are fit for their intended use, comply with the requirements of the Marketing Authorisation or Clinical Trial Authorisation, as appropriate and do not place patients at risk due to inadequate safety, quality or efficacy.
Chronological release history
Version milestone
Publication Date
31 Jan 2013
Effective Date
31 Jan 2013
Download our training programme for 2026–2027 by clicking this link
We use cookies to improve your experience, analyse website usage, and show you relevant information. By accepting all cookies, you help us improve the website. View our privacy statement.
Necessary
Always active. Required for the website to function properly.
Statistics
Helps us improve the website through anonymous statistics.
Marketing
For third-party marketing and tracking cookies.